Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Vitamin D receptor is crucial for starting hair growth after birth.

Steroid injections can help regrow hair in some alopecia cases.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Coudability hairs are useful markers for alopecia areata activity.

Minoxidil helps hair regrowth in alopecia areata safely.

Alopecia patients have lower antioxidants and higher lipid damage in their blood.

Calcitriol-resistant rickets is an inherited disorder that affects hair growth and causes hair loss.

Biotin supplements can effectively treat hair loss and skin issues in certain enzyme deficiencies.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Topical latanoprost and bimatoprost eye solutions don't help eyelash growth in people with alopecia areata.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

A hair-straightening product caused widespread hair loss and scalp injuries, mainly affecting African American women.

Generalized trichoepitheliomas with hair loss may indicate myasthenia gravis.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.